These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35328421)

  • 1. CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy.
    Porika M; Tippani R; Saretzki GC
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology.
    Brane AC; Tollefsbol TO
    Cells; 2019 Feb; 8(2):. PubMed ID: 30795542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Average Telomere Length in Human Telomeric Protein Knockout Cells Generated by CRISPR/Cas9.
    Xu J; Songyang Z; Liu D; Kim H
    Methods Mol Biol; 2017; 1587():15-28. PubMed ID: 28324494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CRISPR base editing approach for the functional assessment of telomere biology disorder-related genes in human health and aging.
    Borges G; Benslimane Y; Harrington L
    Biogerontology; 2024 Apr; 25(2):361-378. PubMed ID: 38310618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression.
    Xi L; Schmidt JC; Zaug AJ; Ascarrunz DR; Cech TR
    Genome Biol; 2015 Nov; 16():231. PubMed ID: 26553065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing
    Dehshahri A; Biagioni A; Bayat H; Lee EHC; Hashemabadi M; Fekri HS; Zarrabi A; Mohammadinejad R; Kumar AP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallmarks of cancer: The CRISPR generation.
    Moses C; Garcia-Bloj B; Harvey AR; Blancafort P
    Eur J Cancer; 2018 Apr; 93():10-18. PubMed ID: 29433054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
    Zhang X; Cheng C; Sun W; Wang H
    Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
    Alagoz M; Kherad N
    Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.